Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCopur, Mazlum
dc.contributor.authorCopur, Sidar
dc.date.accessioned2023-01-30T11:36:49Z
dc.date.available2023-01-30T11:36:49Z
dc.date.issued2019en_US
dc.identifier.citationCopur, M., & Copur, S. (2019). Emergence of tic disorder in a pediatric patient associated with risperidone and aripiprazole treatment. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 20(6), 671-671.en_US
dc.identifier.issn1302-6631
dc.identifier.urihttps://hdl.handle.net/20.500.12294/3197
dc.description.abstractAn atypical anti-psychotic drug, risperidone, used in the treatment of schizophrenia, bipolar mania and irritability associated with autism spectrum disorder works primarily by inhibiting serotonergic (5-HT2A) and dopaminergic (D2) systems. 1 Common adverse effects include cerebrovascular events, tardive dyskinesia, neuroleptic malignant syndrome, orthostatic hypotension, cytopenia, Parkinson-like symptoms, motor impairment, seizures, metabolic alterations and hyperprolactinemia.en_US
dc.language.isoengen_US
dc.publisherCUMHURIYET UNIV TIP FAK PSIKIYATRI ANABILIM DALIen_US
dc.relation.ispartofANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEmergence of tic disorder in a pediatric patient associated with risperidone and aripiprazole treatmenten_US
dc.typeletteren_US
dc.departmentRektörlüken_US
dc.authorid0000-0001-9218-0296en_US
dc.identifier.volume20en_US
dc.identifier.issue6en_US
dc.identifier.startpage671en_US
dc.identifier.endpage671en_US
dc.relation.publicationcategoryDiğeren_US
dc.institutionauthorCopur, Mazlum
dc.authorwosidDWH-8942-2022en_US
dc.authorscopusid8346360900en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.wosWOS:000490862500016en_US
dc.identifier.scopus2-s2.0-85090632098en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster